Acutus Medical, Inc. (AFIB) |
|
0.6966 -0.001 (-0.19%)
|
09-29 16:00 |
|
Open: |
0.7301 |
Pre. Close: |
0.6979 |
|
High:
|
0.7301 |
Low:
|
0.6881 |
|
Volume:
|
48,409 |
Market Cap:
|
20(M) |
|
|
|
Technical analysis |
as of: 2023-09-29 4:25:42 PM |
|
Short-term rate:
|
  |
| Stoxline posted a NEUTRAL today, downgraded from higher rating. Current trend continues, but could change at anytime. It is not a good time to buy or sell. |
|
Mid-term rate:
|
 |
| Target: |
Six months: 0.92 One year: 1.07 |
| Support: |
Support1: 0.54 Support2: 0.4 |
| Resistance: |
Resistance1: 0.79 Resistance2: 0.92 |
| Pivot: |
0.61  |
| Moving Average: |
MA(5): 0.66 MA(20): 0.58
MA(100): 0.73 MA(250): 0.9 |
| MACD: |
MACD(12,26): 0 Signal(9): 0 |
| Stochastic oscillator: |
%K(14,3): 71.8 %D(3): 69.2 |
| RSI: |
RSI(14): 58.6 |
| 52-week: |
High: 1.96 Low: 0.4 |
| Average Vol(K): |
3-Month: 111 (K) 10-Days: 91 (K) |
|
Price, moving averages and Bollinger Bands |
|
Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.[ AFIB ] has closed below upper band by 27.4%. Bollinger Bands are 87.4% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 8 days. This is a sign that the current trend might continue. |
|
|
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
0.73 - 0.74 |
0.74 - 0.74 |
|
Low:
|
0.68 - 0.68 |
0.68 - 0.69 |
|
Close:
|
0.69 - 0.7 |
0.7 - 0.7 |
|
Company Description |
|
Acutus Medical, Inc., an arrhythmia management company, designs, manufactures, and markets a range of tools for catheter-based ablation procedures to treat various arrhythmias in the United States and internationally. The company's product portfolio includes novel access sheaths, transseptal crossing tools, diagnostic and mapping catheters, conventional and contact force ablation catheters, and mapping and imaging consoles and accessories, as well as supporting algorithms and software programs. Acutus Medical, Inc. was incorporated in 2011 and is headquartered in Carlsbad, California. |
Headline News |
Fri, 29 Sep 2023
Electrophysiology Devices Market Size, Growth Challenges, and Future Developments to 2032 - Benzinga
Tue, 26 Sep 2023
Why TD SYNNEX Shares Are Trading Lower By Over 5%? Here Are ... - Investing.com UK
Mon, 25 Sep 2023
Electrophysiology Catheters Market size to grow by USD 2.24 billion ... - PR Newswire
Tue, 08 Aug 2023
Acutus Medical, Inc. (NASDAQ:AFIB) Q2 2023 Earnings Call Transcript - Yahoo Finance
Mon, 07 Aug 2023
Acutus Medical Reports Second Quarter 2023 Financial Results - GlobeNewswire
Mon, 24 Jul 2023
Acutus Medical to Announce Second Quarter 2023 Financial Results - Marketscreener.com
|
Financial Analysis |
| Price to Book Value: |
Neutral |
| P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
| Price to Earnings: |
Outperform |
| PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
| Discounted cash flow: |
Outperform |
| DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
| Return on Assets: |
Outperform |
| ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
| Return on Equity: |
Outperform |
| ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
| Debt to Equity: |
Outperform |
| evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
|
|
|
|
|
|
| Free Technical Analysis Charts
|
|
|
Stock Basics & Statistics |
| Exchange: NASDAQ |
| Sector: Healthcare |
| Industry: Medical Devices |
| Shares Out. |
29 (M) |
| Shares Float |
21 (M) |
|
% Held by Insiders
|
4.2 (%) |
|
% Held by Institutions
|
37.4 (%) |
|
Shares Short
|
242 (K) |
|
Shares Short P.Month
|
214 (K) |
Stock Financials |
|
EPS
|
-1.26 |
|
EPS Est Next Qtl
|
0 |
|
EPS Est This Year
|
0 |
|
EPS Est Next Year
|
0 |
|
Book Value (p.s.)
|
1.5 |
|
Profit Margin (%)
|
-221.4 |
|
Operating Margin (%)
|
-416.2 |
|
Return on Assets (ttm)
|
-39.4 |
|
Return on Equity (ttm)
|
-66.5 |
|
Qtrly Rev. Growth
|
29.7 |
|
Gross Profit (p.s.)
|
-0.54 |
|
Sales Per Share
|
0.61 |
|
EBITDA (p.s.)
|
-2.38 |
|
Qtrly Earnings Growth
|
0 |
|
Operating Cash Flow
|
-65 (M) |
|
Levered Free Cash Flow
|
-50 (M) |
Stock Valuations |
|
PE Ratio
|
-0.56 |
|
PEG Ratio
|
0 |
|
Price to Book value
|
0.46 |
|
Price to Sales
|
1.12 |
|
Price to Cash Flow
|
-0.32 |
Stock Dividends |
|
Dividend
|
0 |
|
Forward Dividend
|
0 |
|
Dividend Yield
|
0% |
|
Dividend Pay Date
|
Invalid DateTime. |
|
Ex-Dividend Date
|
Invalid DateTime. |
|
Your Ad Here
|
|
